NervGen Pharma Corp Reports Q2 Financial Results and Shareholder Update
NervGen Pharma Corp releases second-quarter financial results and provides a letter to shareholders, highlighting progress…
Pharmaceuticals
Medical Research and Policy Updates: A Comprehensive Review
Stay informed about the latest medical research and policy updates, including news, trends, and analysis…
Novartis’ Ianalumab Demonstrates Potential in Phase 3 Sjögren’s Syndrome Trials
Novartis' ianalumab has shown promise in Phase 3 clinical trials for the treatment of Sjögren's…
Novartis Trial Update: Maria Maraggeli Defends Testimony Amid Controversy
Maria Maraggeli, a key witness in the Novartis trial, insists her testimony was true despite…
The Hidden Dangers of Data Exclusivity in Pharmaceuticals: A Threat to Global Health
Data exclusivity in pharma can hinder access to affordable medicines, posing a significant risk to…
Pharmaceutical Influence on US Neurologists: A Growing Concern
A recent study reveals that a majority of US neurologists have financial ties to pharmaceutical…
Zydus Lifesciences Mourns the Loss of Senior Management Personnel
Zydus Lifesciences announces the demise of a senior management personnel, leaving a void in the…
Hemogenyx Pharmaceuticals Secures $570,000 in Funding and Announces Director’s Dealings
Hemogenyx Pharmaceuticals raises $570,000 and announces director's dealings, marking a significant milestone in the company's…
Merz and Carney Sign Historic German-Canadian Partnership
Germany and Canada strengthen economic ties with a new partnership agreement
DMW, Pharmaceutical Firm Unite to Enhance Medical Access for OFW Families
A groundbreaking agreement between the Department of Migrant Workers and a leading pharmaceutical firm aims…